Palestine Development & Investment Co. (PEX:PADICO)
2.200
0.00 (0.00%)
At close: Oct 26, 2026
PEX:PADICO Revenue
Palestine Development & Investment Co. had revenue of $14.36M USD in the quarter ending June 30, 2026, with 63.87% growth. This brings the company's total for the last twelve months to $52.40M. In the year 2025, Palestine Development & Investment Co. had annual revenue of $45.60M with 50.03% growth. That makes Palestine Development & Investment Co. the 27,650th largest company in the world by revenue and 15th in Palestine.
Revenue (ttm)
$52.40M
Revenue Growth
+50.03%
P/S Ratio
10.48
Revenue / Employee
$14.97K
Employees
3,500
Market Cap
389.64M JOD
Revenue by Segment
- Investment Sector 34.78M 74.7%
- Real Estate and Warehousing Services 5.60M 12.0%
- Financial Market 3.47M 7.5%
- Tourism Sector 2.71M 5.8%
Fiscal year ended Dec 31, 2025 See the full PEX:PADICO breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.60M | 15.21M | 50.03% |
| Dec 31, 2024 | 30.39M | -78.92M | -72.20% |
| Dec 31, 2023 | 109.31M | -29.72M | -21.38% |
| Dec 31, 2022 | 139.04M | 6.54M | 4.93% |
| Dec 31, 2021 | 132.50M | 23.94M | 22.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Arab Palestinian Investment Company | 988.69M |
| Palestine Telecommunications Company P.L.C | 321.93M |
| Bank of Palestine | 221.75M |
| Wataniya Palestine Mobile Telecommunication - Public Shareholding Company | 81.62M |
| Arab Islamic Bank P.L.C. | 48.75M |
| Quds Bank | 42.77M |
| The National Bank | 34.39M |
| Birzeit Pharmaceuticals Company | 33.08M |